4DMedical Limited (ASX: 4DX) - ETF Exposure

- Current share price for 4DX : $3.710

4DMedical Limited (4DX) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is a Company engaged in medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging.

4DX General Information ⁺

ASX Code	4DX
Website	N/A
Industry/Sector	Health Care Technology
Market Cap ($M)	2,224
4DX Share Price	$3.710
Day High	$3.810
Day Low	$3.620
Last Close	$3.710
4DX Share Price Movement	- ( No change )

Prices as at 16:40, 17 Aug 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to 4DX

As a significant Australian company by market capitalisation, 4DX is held across 17 ETFs spanning strategies that include health care technology exposure . Its weighting in those funds means performance can have an outsized influence - when 4DX moves, funds like ALFA, ATEC, SSO, ISO and VSO that hold it can move with it.

For more concentrated exposure, ETFs such as ALFA (Vaneck Australian Long Short Complex ETF) allocate about 2.8% to 4DX , while the average exposure across all 17 ETFs that hold it is around 0.5% .

Top ETF holdings

Vaneck Australian Long Short Complex ETF (ALFA) ~ 2.8%
BetaShares S&P/ASX Australian Technology ETF (ATEC) ~ 1.8%
SPDR S&P/ASX Small Ordinaries Fund (SSO) ~ 0.7%
iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO) ~ 0.6%
Vanguard MSCI Australian Small Companies Index ETF (VSO) ~ 0.4%

Last updated: ETF data and holdings as at 17 August 2026

Own 4DX directly or through an ETF?

How does holding 4DMedical Limited (4DX) shares directly compare to ETFs that include it?

	4DX Direct	ALFA ASX	ATEC ASX	SSO ASX	ISO ASX	VSO ASX
Holdings	1 company	70 holdings	46 holdings	201 holdings	198 holdings	193 holdings
4DX Weight	100%	2.8%	1.8%	0.7%	0.6%	0.4%
Diversification	Single Stock	Broad	Broad	Broad	Broad	Broad
Annual Cost	Brokerage only	0.39% p.a.	0.48% p.a.	0.5% p.a.	0.55% p.a.	0.3% p.a.
Approx. Yield	-	0.87%	1.72%	8.95%	4.19%	4.63%
Star Ratings	-

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not 4DX's direct yield. Annual cost uses each ETF's MER.

4DX Exposure on $10,000 investment

How a $10,000 investment in 4DMedical Limited (4DX) one week ago compares with ETFs that hold it.

Security	Investment type	Current price	7-day price movement	Dollar change	Value today
4DMedical Limited (4DX)	Direct share	$3.710	-15.68%	-$1,568	$8,432
Vaneck Australian Long Short Complex ETF (ALFA)	Equity - Australia Strategy	$22.880	-0.13%	-$13	$9,987
BetaShares S&P/ASX Australian Technology ETF (ATEC)	Equity - Australia Sectors	$24.030	-0.04%	-$4	$9,996
SPDR S&P/ASX Small Ordinaries Fund (SSO)	Equity - Australia Small/Mid Cap	$14.990	-0.86%	-$86	$9,914
iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO)	Equity - Australia Small/Mid Cap	$5.220	-0.38%	-$38	$9,962
Vanguard MSCI Australian Small Companies Index ETF (VSO)	Equity - Australia Small/Mid Cap	$75.500	-0.83%	-$83	$9,917

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

4DMedical Limited (4DX) ETFs

17 ETFs hold 4DMedical Limited (4DX).

ETF	4DX Weight	MER	Yield
Vaneck Australian Long Short Complex ETF (ALFA)	2.8%	0.39%	0.87%
BetaShares S&P/ASX Australian Technology ETF (ATEC)	1.8%	0.48%	1.72%
SPDR S&P/ASX Small Ordinaries Fund (SSO)	0.7%	0.5%	8.95%
iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO)	0.6%	0.55%	4.19%
Vanguard MSCI Australian Small Companies Index ETF (VSO)	0.4%	0.3%	4.63%
eInvest Better Future (Managed Fund) (IMPQ)	0.4%	0.89%	2.05%
Betashares Australian Momentum ETF (MTUM)	0.3%	0.35%	2.16%
Global X Australia ex Financials & Resources ETF (OZXX)	0.3%	0.25%	5.13%
Betashares Australian Ex-20 Portfolio Diversifier ETF (EX20)	0.2%	0.25%	2.7%
Betashares Geared Australian Equity Fund (GEAR)	0.2%	2.11%	1.73%

View all 17 ETFs

4DMedical Limited (4DX) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield

See all dividends from 4DMedical Limited (4DX) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

4DMedical Limited (4DX) price-sensitive announcements

4DX - Quarterly Activity Report and Appendix 4C

4DMedical Limited has released its Quarterly Activity Report and Appendix 4C for the quart

4DMedical Limited (4DX)
31 Jul 2026 | 10:13 AM

4DX - US Bill directs VA to adopt 4D lung imaging

4DMedical Limited announced the introduction of a bipartisan bill in the US House of Repre

4DMedical Limited (4DX)
16 Jul 2026 | 12:31 PM

4DX - Trading Halt

4DMedical Limited (ASX: 4DX) requested a trading halt on its securities from the Australia

4DMedical Limited (4DX)
16 Jul 2026 | 10:45 AM

4DX - Pause in trade

On 16th July 2026, the Australian Securities Exchange (ASX) announced a temporary pause in

4DMedical Limited (4DX)
16 Jul 2026 | 10:00 AM

4DMedical Limited (4DX) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
4DMedical Limited (4DX) ORDINARY FULLY PAID	Health Care	$2,225	Application for quotation of securities - 4DX	14 Aug 2026 4:00PM	$3.660	$3.710	risen by 1.37%
4DMedical Limited (4DX) ORDINARY FULLY PAID	Health Care	$2,225	Cleansing Notice	13 Aug 2026 4:43PM	$3.910	$3.710	fallen by 5.12%
4DMedical Limited (4DX) ORDINARY FULLY PAID	Health Care	$2,225	Application for quotation of securities - 4DX	13 Aug 2026 4:37PM	$3.910	$3.710	fallen by 5.12%
4DMedical Limited (4DX) ORDINARY FULLY PAID	Health Care	$2,225	Update - Proposed issue of securities - 4DX	10 Aug 2026 4:44PM	$4.400	$3.710	fallen by 15.68%
4DMedical Limited (4DX) ORDINARY FULLY PAID	Health Care	$2,225	Update - Proposed issue of securities - 4DX	31 Jul 2026 4:46PM	$3.630	$3.710	risen by 2.20%
4DMedical Limited (4DX) ORDINARY FULLY PAID	Health Care	$2,225	Quarterly Activity Report and Appendix 4C	31 Jul 2026 10:13AM	$3.330	$3.710	risen by 11.41%

4DX Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	Yield (%)	Franking (%)
2025A	-$29.41	-$13.70	33.00%	0.00%	0.0%
2024A	-$33.66	-$10.30	-1.90%	0.00%	0.0%
2023A	-$31.46	-$10.50	-10.90%	0.00%	0.0%

4DX Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2023 A	2024 A	2025 A	2023 A	2024 A	2025 A	2023 A	2024 A	2025 A
4DMedical Limited (4DX)	$2,183M	0.3304	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Pro Medicus Limited (PME)	$18,685M	0.3919	0.2545	0.2962	162.4523	129.4961	99.9050	0.31%	0.39%	0.51%

4DX Directors

Name	Position	Start Date
Dr Andreas Fouras	Chief Executive Officer, Managing Director	17 Dec 2012
Mr John Andrew Livingston	Executive Director	7 Mar 2018
Dr Robert Alan Figlin	Non-Executive Director	9 Dec 2016
Mr Julian Bernard Kingsley Sutton	Non-Executive Director	15 Sep 2017
Dr Geraldine Bernadette McGinty	Non-Executive Director	25 Sep 2023
Ms Lilian (Lil) Bianchi	Non-Executive Director, Non-Executive Chairman	11 Dec 2019

4DMedical Limited (4DX) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
19 Jun 2026	SUTTON, Julian	Buy	Direct Shares	11,363	$4.400	$49,997.200
18 Jun 2026	SUTTON, Julian	Buy	Direct Shares	13,054	$3.830	$49,996.820
21 Jan 2026	FOURAS, Andreas	Sell	Indirect Shares	263,157	$3.800	$999,996.600

See all changes in directors' interest & trades for 4DMedical Limited (4DX) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

4DX Management

Name	Position
Matt Tucker	Chief Commercial Officer
Hamish George	Company Secretary

4DX Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in 4DMedical Limited (4DX). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
65,701,465 (13.31%)	Helen Fouras

4DX Calendar of Events

Date	Event
26 February 2027	Report (Interim)
25 September 2026	Report (Annual)
28 August 2026	Report (Prelim)
18 August 2026	Issued Shares

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us